Firuglipel

Names

[ Name ]:
Firuglipel

[Synonym ]:
4-(5-{(1R)-1-[4-(Cyclopropylcarbonyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluoro-N-[(2R)-1-hydroxy-2-propanyl]benzamide

Biological Activity

[Description]:

Firuglipel (DS-8500a) is an orally available, potent and selective GPR119 agonist.

[Related Catalog]:

Signaling Pathways >> GPCR/G Protein >> GPR119

Research Areas >> Metabolic Disease

[Target]

GPR119[1]

[In Vitro]

Firuglipel (DS-8500a) increases intracellular cAMP in a concentration-dependent manner in human, rat, and mouse GPR119-expressing Chinese hamster ovary (CHO)-K1 cells, with EC50 values of 51.5, 98.4, and 108.1 nM, respectively. DS-8500a has no effect on intracellular cAMP in pcDNA3.1/CHO-K1 cells[1].

[In Vivo]

Firuglipel (DS-8500a) (1-30 mg/kg) upregulates glucagon-like peptide-1 and enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats[1].

[Animal admin]

Rats[1] Male SD rats (8 weeks) are fasted overnight and orally given vehicle (0.5% MC), DS-8500a (0.1, 1, 3 and 10 mg/kg), or glimepiride (10 mg/kg). Thirty minutes later, all animals received a 50% glucose solution intravenously (glucose load: 0.5 g/kg). Blood collection is performed from the tail vein 35 minutes before, 5 minutes before, and 5 minutes after the glucose load. The plasma insulin concentration is measured using ELISA kits.

[References]

[1]. Matsumoto K, et al. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats. J Pharmacol Exp Ther. 2018 Dec;367(3):509-517.

[Related Small Molecules]

AR 231453 | MBX-2982 | JNJ-38431055 | PSN632408 | GSK1292263 | APD 668

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Molecular Formula ]:
C₂₅H₂₆FN₃O₅

[ Molecular Weight ]:
467.489

[ Exact Mass ]:
467.185638

[ LogP ]:
3.51

[ Index of Refraction ]:
1.592

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.